[Skin decontamination in the use of indium oxinate for cell labelling].
D001792:Blood Platelets / Q000000981:diagnostic imaging; D006801:Humans; D006912:Hydroxyquinolines / Q000009:adverse effects*; D007204:Indium / Q000009:adverse effects*; D009784:Occupational Diseases / Q000517:prevention & control*; D009942:Organometallic Compounds; D015125:Oxyquinoline / Q000009:adverse effects* / Q000031:analogs & derivatives; D010422:Pentanones / Q000009:adverse effects; D011835:Radiation Protection / Q000379:methods*; D011855:Radiodermatitis / Q000517:prevention & control*; D011868:Radioisotopes / Q000009:adverse effects*; D011877:Radionuclide Imaging
D006912:Hydroxyquinolines; D009942:Organometallic Compounds; D010422:Pentanones; D011868:Radioisotopes; D007204:Indium; C032950:indium oxine; C008790:acetylacetone; D015125:Oxyquinoline
Hautdekontamination beim Umgang mit Indium-Oxinat zur Zellmarkierung.